The World of Health & Medicine News

Excessive social media use linked to delusional disorders

Excessive social media use linked to delusional disorders

A new study from researchers at Simon Fraser University has found a strong link between high levels of social media use and psychiatric disorders involving delusions, such as narcissism and body dysmorphic disorder.

According to the study, published in BMC Psychiatry — a systematic review of all available academic research, including a detailed review of more than 2,500 publications on social media use and psychiatric disorders — delusional forms are by far the most common type of psychiatric disorder linked to excessive social media use.

These disorders include: narcissistic personality disorder (delusions of superiority), narcissistic delusions (delusions that a famous person is in love with you), body dysmorphic disorder (delusions of a flaw in a part of one’s body), and anorexia (caused by delusions about body size).

According to the study’s authors, social media itself is not inherently problematic, but virtual worlds – combined with social isolation in “real life” – create environments in which people can maintain an illusory sense of identity without being questioned.

spot_img

Explore more

spot_img

New lasso-shaped antibiotic kills drug-resistant bacteria

New lasso-shaped antibiotic kills drug-resistant bacteria Researchers at McMaster University have identified a new molecule with antibiotic activity against a range of disease-causing bacteria, including...

Chinese brain chip project speeds up human trials after first success

Chinese brain chip project speeds up human trials after first success A tie-up between a Chinese research institute and tech company said on Monday that...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by...

Experimental drug lepodesiran reduces genetic risk factor for heart disease by 94 percent According to results published in the New England Journal of Medicine: In a...

Novo Nordisk to license obesity drug from Lexicon in up to...

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O),...

Vykat XR approved for genetic binge eating disorder

For the first time/ Vykat XR approved for genetic binge eating disorder The U.S. Food and Drug Administration (FDA) on Wednesday approved Soleno Therapeutics’ drug to...

Keytruda subcutaneous injection to launch on October 1

Keytruda subcutaneous injection to launch on October 1 Merck & Co. said Thursday it plans to launch a subcutaneous injection of its best-selling cancer immunotherapy,...

Buying an autoimmune disease drug for $1.3 billion

Sanofi/ Buying an autoimmune disease drug for $1.3 billion Sanofi announced Thursday that it has agreed to buy the biopharmaceutical company’s autoimmune disease drug Dren Bio...

US FDA approves Sanofi’s bleeding disorder therapy

US FDA approves Sanofi's bleeding disorder therapy The U.S. Food and Drug Administration approved French drugmaker Sanofi's (SASY.PA), opens new tab hemophilia therapy, introducing a new...